AYTU

Aytu BioPharma, Inc. AYTU

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode AYTU PRPH BFRI EKSO TXMD ANL NVNO OSRH ALUR GOVX
6M 17.67 % -82.38 % 15.33 % 73.65 % 42.86 % -6.71 % -91.59 % -53.43 % -43.50 % -79.74 %
YTD 48.82 % -93.01 % -33.94 % -41.43 % 8.28 % -37.30 % -88.44 % -94.87 % -86.67 % -92.67 %
1Y 65.36 % -90.18 % -32.71 % -41.31 % 55.96 % -30.45 % -88.41 % -94.87 % -87.17 % -92.27 %
3Y -33.42 % -98.71 % -95.76 % -68.83 % -67.56 % -89.80 % -92.20 % -94.87 % -99.45 % -97.80 %
5Y -97.96 % -98.88 % -99.18 % -94.47 % -97.21 % -89.80 % -95.61 % -94.87 % -99.43 % -99.64 %
10Y -100.00 % -98.00 % -99.18 % -99.68 % -99.69 % -89.80 % -99.73 % -94.87 % -99.43 % -99.59 %
From the beginning -100.00 % -75.40 % -99.18 % -99.85 % -99.96 % -89.80 % -99.73 % -94.87 % -99.43 % -99.59 %

Dividend

ProPhase Labs, Inc.